Latest Views & analysis
Gaining a clear view of supply chain visibility
In the pharma industry, companies need to know where products are at any point in the supply chain, but with one of the most complex systems of any industry, what are the pressure points and how can they be managed?
Interview: David Mitchell of Patients For Affordable Drugs
In the latest edition of our Deep Dive magazine – Deep Dive: Patient Centricity II – David Mitchell, President of Patients For Affordable Drugs, speaks to pharmaphorum’s Andrew McConaghie about why the organisation was set up and why its campaigning work is so important for patients.
Recommended authors
More Views & Analysis
Bahija Jallal: pharma’s Woman of the Year in a landmark 12 months
AstraZeneca’s Bahija Jallal was named the Healthcare Businesswomen’s Association (HBA) Women of the Year for 2017 – in what turned out to a watershed year for women’s rights.
Why pharma’s manufacturing supply chain needs blockchain innovation
There are many challenges in the pharmaceutical supply chain, from maintaining quality to security issues. Can blockchain provide the end-to-end visibility needed?
Brexit makes UK pharma market less attractive – can a more collaborative culture redeem it?
A UK market access summit convened by IQVIA brought together pharma and NHS leaders to look at how working more closely – including more outcomes-based deals – could help UK life sciences through Brexit and beyond.
